UA86813C2 - Ингибиторы бета-гидроксистероидной дегидрогеназы типа 1 - Google Patents

Ингибиторы бета-гидроксистероидной дегидрогеназы типа 1

Info

Publication number
UA86813C2
UA86813C2 UAA200613767A UAA200613767A UA86813C2 UA 86813 C2 UA86813 C2 UA 86813C2 UA A200613767 A UAA200613767 A UA A200613767A UA A200613767 A UAA200613767 A UA A200613767A UA 86813 C2 UA86813 C2 UA 86813C2
Authority
UA
Ukraine
Prior art keywords
dehydrogenase type
inhibitors
beta
steroid dehydrogenase
hydroxy steroid
Prior art date
Application number
UAA200613767A
Other languages
English (en)
Ukrainian (uk)
Inventor
Мартин Хенрикссон
Эверт Хоман
Ларс ЙОХАНССОН
Йерк Валлгарда
Мередит Уильямс
Эрик Беркот
Кристофер Х. Фотсч
Айвен Ли
Гуолин Кей
Рендалл У. Хангейт
Честер Ченгуанг Юан
Кристофер Тигли
Джин Девид Ст.
Найанхе Хен
Куи Хуанг
Куингюян Лиу
Майкл Д. Бартбергер
Джордж А. Мониз
Меттью Дж. Фриззл
Original Assignee
Амген Инк.
Байовитрум Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амген Инк., Байовитрум Аб filed Critical Амген Инк.
Publication of UA86813C2 publication Critical patent/UA86813C2/ru

Links

UAA200613767A 2004-05-24 2005-05-24 Ингибиторы бета-гидроксистероидной дегидрогеназы типа 1 UA86813C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401324A SE0401324D0 (sv) 2004-05-24 2004-05-24 New compounds

Publications (1)

Publication Number Publication Date
UA86813C2 true UA86813C2 (ru) 2009-05-25

Family

ID=32589784

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200613767A UA86813C2 (ru) 2004-05-24 2005-05-24 Ингибиторы бета-гидроксистероидной дегидрогеназы типа 1

Country Status (4)

Country Link
SE (1) SE0401324D0 (ru)
TN (1) TNSN06372A1 (ru)
UA (1) UA86813C2 (ru)
ZA (1) ZA200609764B (ru)

Also Published As

Publication number Publication date
ZA200609764B (en) 2008-02-27
SE0401324D0 (sv) 2004-05-24
TNSN06372A1 (en) 2008-02-22

Similar Documents

Publication Publication Date Title
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007061661A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200615266A (en) Organic compounds
WO2005075471A3 (en) Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
SG170828A1 (en) Deazapurines useful as inhibitors of janus kinases
UA92348C2 (en) 17b-HSD1 AND STS INHIBITORS
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
WO2006067165A3 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
TW200611695A (en) Pyrrolopyridine derivatives
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
EP1725536B8 (en) Imidazoline derivatives having cb1-antagonistic activity
WO2006116733A3 (en) Protein kinase inhibitors
MY138708A (en) Biaryloxymethylarenecarboxylic acids
WO2008034796A3 (en) Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors